The report focuses on the Tuberculosis Diagnostics market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Tuberculosis Diagnostics market.
Major Players in the Tuberculosis Diagnostics market are:
bioM?rieux SA
Cepheid
Alere, Inc.
Becton, Dickinson and Company
F. Hoffmann-La Roche AG
Abbott Laboratories
Thermo Fisher Scientific, Inc.
Sanofi
Hologic Corporation
Hain Lifescience GmbH
QIAGEN
On the basis of types, the Tuberculosis Diagnostics market is primarily split into:
NAAT
Culture
On the basis of applications, the market covers:
Hospital
Clinic
Major Regions or countries covered in this report:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029
Table of Content
1 Tuberculosis Diagnostics Market Overview
1.1 Product Overview and Scope of Tuberculosis Diagnostics Market
1.2 Tuberculosis Diagnostics Market Segment by Type
1.2.1 Global Tuberculosis Diagnostics Market Sales and CAGR (%) Comparison by Type (2017-2029)
1.3 Global Tuberculosis Diagnostics Market Segment by Application
1.3.1 Tuberculosis Diagnostics Market Consumption (Sales) Comparison by Application (2017-2029)
1.4 Global Tuberculosis Diagnostics Market, Region Wise (2017-2029)
1.4.1 Global Tuberculosis Diagnostics Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2029)
1.4.2 United States Tuberculosis Diagnostics Market Status and Prospect (2017-2029)
1.4.3 Europe Tuberculosis Diagnostics Market Status and Prospect (2017-2029)
1.4.4 China Tuberculosis Diagnostics Market Status and Prospect (2017-2029)
1.4.5 Japan Tuberculosis Diagnostics Market Status and Prospect (2017-2029)
1.4.6 India Tuberculosis Diagnostics Market Status and Prospect (2017-2029)
1.4.7 Southeast Asia Tuberculosis Diagnostics Market Status and Prospect (2017-2029)
1.4.8 Latin America Tuberculosis Diagnostics Market Status and Prospect (2017-2029)
1.4.9 Middle East and Africa Tuberculosis Diagnostics Market Status and Prospect (2017-2029)
1.5 Global Market Size (Revenue) of Tuberculosis Diagnostics (2017-2029)
1.5.1 Global Tuberculosis Diagnostics Market Revenue Status and Outlook (2017-2029)
1.5.2 Global Tuberculosis Diagnostics Market Sales Status and Outlook (2017-2029)
1.6 Influence of Regional Conflicts on the Tuberculosis Diagnostics Industry
1.7 Impact of Carbon Neutrality on the Tuberculosis Diagnostics Industry
2 Tuberculosis Diagnostics Market Upstream and Downstream Analysis
2.1 Tuberculosis Diagnostics Industrial Chain Analysis
2.2 Key Raw Materials Suppliers and Price Analysis
2.3 Key Raw Materials Supply and Demand Analysis
2.4 Market Concentration Rate of Raw Materials
2.5 Manufacturing Process Analysis
2.6 Manufacturing Cost Structure Analysis
2.6.1 Labor Cost Analysis
2.6.2 Energy Costs Analysis
2.6.3 R&D Costs Analysis
2.7 Major Downstream Buyers of Tuberculosis Diagnostics Analysis
2.8 Impact of COVID-19 on the Industry Upstream and Downstream
3 Players Profiles
3.1 bioM